46 results on '"Ade, Carsten P."'
Search Results
2. Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers
3. Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival
4. Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II.
5. Association with TFIIIC limits MYCN localization in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA Polymerase II
6. Nucleolar detention of NONO shields DNA double-strand breaks from aberrant transcripts
7. Combined inhibition of Aurora-A and ATR kinases results in regression of MYCN-amplified neuroblastoma
8. The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
9. A MYC–GCN2–eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer
10. Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers
11. Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymerase
12. Data from Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
13. Figure S6 from MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
14. Supplementary Information from Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
15. Supplementary Figures 1-7 from Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
16. Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration
17. Correction: The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
18. Expression of the cytokinesis regulator PRC1 results in p53-pathway activation in A549 cells but does not directly regulate gene expression in the nucleus
19. Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration
20. RNA polymerase I inhibition induces terminal differentiation, growth arrest, and vulnerability to senolytics in colorectal cancer cells
21. Expression of the cytokinesis regulator PRC1 results in p53-pathway activation in A549 cells but does not directly regulate gene expression in the nucleus.
22. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
23. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase
24. MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma
25. Intracellular Staphylococcus aureus Perturbs the Host Cell Ca+ Homeostasis To Promote Cell Death
26. Family 34 glycosyltransferase (GT34) genes and proteins in Pinus radiata (radiata pine) and Pinus taeda (loblolly pine)
27. Ubiquitylation of MYC couples transcription elongation with double-strand break repair at active promoters
28. Intracellular Staphylococcus aureus Perturbs the Host Cell Ca 2+ Homeostasis To Promote Cell Death
29. Correction: The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
30. IntracellularStaphylococcus aureusperturbs the host cell Ca2+-homeostasis to promote cell death
31. Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes
32. The adrenergic-induced ERK3 pathway drives lipolysis and suppresses energy dissipation
33. Maintaining protein stability of ∆Np63 via USP 28 is required by squamous cancer cells
34. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
35. Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes
36. Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells
37. The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes
38. Protein kinase D1 deletion in adipocytes enhances energy dissipation and protects against adiposity
39. Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells.
40. Cell Type and Species-specific Patterns in Neuronal and Non-neuronal Methylomes of Human and Chimpanzee Cortices
41. The MYC mRNA 3′‐UTR couples RNA polymerase II function to glutamine and ribonucleotide levels
42. NOTCH , ASCL1 , p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
43. Tumor cell‐specific inhibition of MYC function using small molecule inhibitors of the HUWE 1 ubiquitin ligase
44. Generation of a pooled shRNA library for functional genomics screens
45. Intracellular Staphylococcus aureusPerturbs the Host Cell Ca2+Homeostasis To Promote Cell Death
46. Combined inhibition of Aurora-A and ATR kinases results in regression of MYCN-amplified neuroblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.